Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

824 public trials 109 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours

NCT00875433

Conditions: Neoplasms
Locations: 1200.24.4403 Boehringer Ingelheim Investigational Site Guildford, United Kingdom

1200.24.4402 Boehringer Ingelheim Investigational Site London, United Kingdom

1200.24.4404 Boehringer Ingelheim Investigational Site London, United Kingdom

1200.24.4401 Boehringer Ingelheim Investigational Site Sutton, United Kingdom

View Trial Details

Completed

The Usefulness of Endoscopic Ultrasound-guided Biliary Drainage With a Newly Designed Hybrid Metallic Stent

NCT01862198

Conditions: Bile Duct Diseases, Bile Duct Obstruction, Biliary Tract Diseases, +4 more
Locations: Inje University Ilsan Paik Hospital Koyang, South Korea

Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Phase I Study of BI 831266 in Patients With Advanced Solid Tumours

NCT00756223

Conditions: Neoplasms
Locations: 1257.1.4303 Boehringer Ingelheim Investigational Site Linz, Austria

1257.1.4302 Boehringer Ingelheim Investigational Site Salzburg, Austria

1257.1.4301 Boehringer Ingelheim Investigational Site Vienna, Austria

View Trial Details

Completed

Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors

NCT01096030

Conditions: Neoplasms
Locations: Shatin, N.T, Hong Kong

Hong Kong

Singapore

Singapore

View Trial Details

Completed

A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients

NCT00545246

Conditions: Neoplasms
Locations: Sanofi-Aventis Investigational Site Number 392002 Iruma-gun, Japan

Sanofi-Aventis Investigational Site Number 392001 Sunto-Gun, Japan

View Trial Details

Completed

A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing

NCT01811095

Conditions: Neoplasms
Locations: Royal Victoria Hospital Montreal, Quebec, Canada

Jewish General Hospital Montreal, Quebec, Canada

View Trial Details

Completed

A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

NCT00516945

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Queen Elizabeth Hospital Hong Kong, China

View Trial Details

Completed

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

NCT00569036

Conditions: Metastases, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Local Institution East Melbourne, Victoria, Australia

Local Institution Footscray, Victoria, Australia

Local Institution Heidelberg, Victoria, Australia

Local Institution Parkville, Victoria, Australia

View Trial Details

Completed

Mindfulness-based Stress Reduction in Cancer Treatment

NCT01303822

Conditions: Neoplasms
Locations: Kliniken Essen-Mitte, Knappschafts-Krankenhaus, Department for Internal and Integrative Medicine Essen, North Rhine-Westphalia, Germany

View Trial Details

Completed

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

NCT00443534

Conditions: Neoplasms
Locations: Pfizer Investigational Site Aurora, Colorado, United States

Pfizer Investigational Site Littleton, Colorado, United States

Pfizer Investigational Site Orlando, Florida, United States

Pfizer Investigational Site Atlanta, Georgia, United States

View all 62 locations

View Trial Details